TECHLAB Receives FDA 510(k) Clearance To Market CAMPYLOBACTER QUIK CHEK(TM) and CAMPYLOBACTER CHEK(TM) Tests
Tests Help Clinicians Diagnose Diarrhea Caused by Campylobacter Bacteria BLACKSBURG, Va., Jan. 23, 2018 -- (Healthcare Sales & Marketing Network) -- TECHLAB, Inc., a leading developer and manufacturer of rapid non-invasive diagnostic tests for gastroin... Diagnostics, Gastroenterology, Product Launch TECHLAB, CAMPYLOBACTER, QUIK CHEK (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 23, 2018 Category: Pharmaceuticals Source Type: news

Disarm Therapeutics Appoints Thomas Engber as Senior Vice President, Head of Neuropharmacology and Translational Sciences
CAMBRIDGE, Mass., Jan. 23, 2018 -- (Healthcare Sales & Marketing Network) -- Disarm Therapeutics, a biotechnology company creating a new class of disease-modifying therapeutics for patients with axonal degeneration, a central driver of neurological diseas... Biopharmaceuticals, Neurology, Personnel Disarm Therapeutics, axonal degeneration (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 23, 2018 Category: Pharmaceuticals Source Type: news

Johnson and Johnson Vision Expands Parameter Offering for 1-DAY ACUVUE(R) MOIST Brand Contact Lenses for ASTIGMATISM
Nearly half of vision-corrected patients has astigmatism in at least one eye,(1) and full correction can provide improved visual quality of life(2) JACKSONVILLE, Fla., Jan. 22, 2018 -- (Healthcare Sales & Marketing Network) -- Johnson & Johnson Vision ... Devices, Ophthalmology, Product Launch Johnson & Johnson, Johnson & Johnson Vision, ACUVUE MOIST (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 22, 2018 Category: Pharmaceuticals Source Type: news

Symic Bio Appoints Hicham Alaoui, Ph.D., as Senior Vice President of Discovery Biology
SAN FRANCISCO, Jan. 22, 2018 -- (Healthcare Sales & Marketing Network) -- Symic Bio, a biopharmaceutical company developing novel matrix-targeting biotherapeutics, today announced the appointment of Hicham Alaoui, Ph.D., as Senior Vice President of Discov... Biopharmaceuticals, Personnel Symic Bio, matrix-targeting biotherapeutics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 22, 2018 Category: Pharmaceuticals Source Type: news

Hologic's Cynosure Division Launches TempSure(TM) Envi
Superior Radiofrequency Treatment Minimizes Fine Facial Lines and Wrinkles, Tightens Skin Through Soft Tissue Coagulation, and Improves the Appearance of Cellulite MARLBOROUGH, Mass., Jan. 22, 2018 -- (Healthcare Sales & Marketing Network) -- Hologic's... Devices, Dermatology, Product Launch Hologic, TempSure (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 22, 2018 Category: Pharmaceuticals Source Type: news

Elanco Animal Health Announces U.S. Food and Drug Administration (FDA) Approval of Credelio(R) (lotilaner) to Treat and Protect Against Ticks and Fleas
New monthly oral tick and flea treatment offers easy dosing, efficacy in as little as four hours, all month long GREENFIELD, Ind., Jan. 22, 2018 -- (Healthcare Sales & Marketing Network) -- Today, Elanco Animal Health, a division of Eli Lilly and Comp... Biopharmaceuticals, FDA Elanco Animal Health, Eli Lilly, Credelio, lotilaner (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 22, 2018 Category: Pharmaceuticals Source Type: news

AVACEN Medical Device for Autistic Spectrum Disorder Behavior Management Launched in Hong Kong
50% Discounted Launch Price Offered SAN DIEGO, Jan. 22, 2018 -- (Healthcare Sales & Marketing Network) -- AVACEN Medical, Inc. (AVACEN) announced that it is launching sales of its AVACEN 100, an FDA-cleared and CE marked, class II dry-heat therapy medi... Devices, Product Launch AVACEN Medical, AVACEN 100, autistic spectrum disorder (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 22, 2018 Category: Pharmaceuticals Source Type: news

Fred Colen Appointed Chief Executive Officer of Neovasc Inc.
NCOUVER, Jan. 22, 2018 -- (Healthcare Sales & Marketing Network) - Neovasc Inc. ("Neovasc" or the "Company") (Nasdaq, TSX: NVCN), a front-runner in minimally invasive transcatheter mitral valve technologies today announced that its boa... Devices, Interventional, Cardiology, Personnel Neovasc , Reducer, Tiara, transcatheter (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 22, 2018 Category: Pharmaceuticals Source Type: news

Regeneron Announces Approval of DUPIXENT(R) (dupilumab) in Japan for the Treatment of Atopic Dermatitis
TARRYTOWN, N.Y., Jan. 22, 2018 -- (Healthcare Sales & Marketing Network) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the Ministry of Health, Labor and Welfare (MHLW) in Japan has granted marketing and manufacturing authorization... Biopharmaceuticals, Dermatology, Regulatory Regeneron Pharmaceuticals, Sanofi, DUPIXENT, dupilumab, atopic dermatitis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 22, 2018 Category: Pharmaceuticals Source Type: news

Titan In Discussions With Braeburn Regarding U.S. Probuphine(R) Commercialization
SOUTH SAN FRANCISCO, Calif., Jan. 22, 2018 -- (Healthcare Sales & Marketing Network) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP), a company developing proprietary therapeutics for the treatment of select chronic diseases utilizing its ProNeura™ long-ter... Biopharmaceuticals Titan Pharmaceuticals, Braeburn Pharmaceuticals, ProNeura, Probuphine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 22, 2018 Category: Pharmaceuticals Source Type: news

Astellas and Vical Announce Top-Line Results for Phase 3 Trial of Cytomegalovirus Vaccine ASP0113 in Hematopoietic Stem Cell Transplant Recipients
TOKYO and SAN DIEGO, Jan. 22, 2018 -- (Healthcare Sales & Marketing Network) -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko Hatanaka, "Astellas") and Vical Incorporated (NASDAQ: VICL) announced today that ASP0113, an investigat... Biopharmaceuticals Astellas Pharma, Vical , cytomegalovirus (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 22, 2018 Category: Pharmaceuticals Source Type: news

MyoKardia Announces Appointment of Cynthia Ladd as General Counsel
SOUTH SAN FRANCISCO, Calif., Jan. 19, 2018 -- (Healthcare Sales & Marketing Network) -- MyoKardia, Inc. (Nasdaq:MYOK), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable cardiovascular disease... Biopharmaceuticals, Cardiology, Personnel MyoKardia, cardiomyopathy, mavacamten (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 19, 2018 Category: Pharmaceuticals Source Type: news

UPM Pharmaceuticals appoints Chris Curtin as Chief Operating Officer
40 years of industry experience in domestic and international markets related to Quality, Manufacturing, Supply Chain, Pharmaceutical Technology and Engineering BRISTOL, Tenn., Jan. 19, 2018 -- (Healthcare Sales & Marketing Network) -- UPM Pharmaceutic... Biopharmaceuticals, Personnel UPM Pharmaceuticals (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 19, 2018 Category: Pharmaceuticals Source Type: news

Gathering Together World-Renowned Medical Device Manufacturing Suppliers, Medtec China Helps to Propel the Medical Device Localization Process
SHANGHAI, Jan. 19, 2018 -- (Healthcare Sales & Marketing Network) -- To deliver a boost to the Medical Device Industry in China, the Chinese government has proactively launched several policies directed at medical device innovation which focus on speeding... Devices, Regulatory Medtec China (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 19, 2018 Category: Pharmaceuticals Source Type: news

Independent Imaging Review Confirmed Positive Data from Primary Analysis of REFLECT Trial Evaluating Lenvatinib Compared to Sorafenib in Unresectable Hepatocellular Carcinoma
Results of tumor response assessments by blinded independent imaging review using both mRECIST and RECIST v1.1 criteria to be presented today at the Gastrointestinal Cancers Symposium WOODCLIFF LAKE, N.J., Jan. 19, 2018 -- (Healthcare Sales & Marketing ... Biopharmaceuticals, Oncology Eisai, REFLECT study, lenvatinib, Lenvima, hepatocellular carcinoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 19, 2018 Category: Pharmaceuticals Source Type: news

Clinical Genomics appoints Tadd Lazarus, M.D., as Chief Medical Officer
BRIDGEWATER, N.J., Jan. 18, 2018 -- (Healthcare Sales & Marketing Network) -- Clinical Genomics, a leading provider of cancer diagnostic solutions and liquid biopsy tests, today announced the appointment of Tadd Lazarus, M.D., as Chief Medical Officer. La... Diagnostics, Oncology, Personnel Clinical Genomics, colorectal cancer, COLVERA, liquid biopsy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 18, 2018 Category: Pharmaceuticals Source Type: news

New Registry Launched to Track and Improve the Quality of Cancer Care Delivered in the U.S.
Quality Oncology Practice Initiative (QOPI®) Reporting Registry is a Joint Effort of Two Leading Oncology Societies ALEXANDRIA, Va., Jan. 18, 2018 -- (Healthcare Sales & Marketing Network) -- A registry that tracks the quality of medical care provid... Devices, Oncology, Product Launch ASTRO, ASCO, Quality Oncology Practice Initiative, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 18, 2018 Category: Pharmaceuticals Source Type: news

Smith and Nephew's Episode of Care Assurance Program (eCAP) reduces hospital readmission following total joint replacement surgery
LONDON, Jan. 18, 2018 -- (Healthcare Sales & Marketing Network) -- Smith & Nephew (NYSE: SNN; LSE: SN), the global medical technology business, today announces results showing a near 75% decrease in readmission rates for joint arthroplasties (TJA) conduct... Devices, Orthopaedic Smith & Nephew, Episode of Care Assurance Program, total joint arthroplasty (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 18, 2018 Category: Pharmaceuticals Source Type: news

Aquestive Therapeutics Announces U.S. FDA Filing Acceptance of New Drug Application for Clobazam Oral Soluble Film to Treat Lennox-Gastaut Syndrome
WARREN, N.J., Jan. 18, 2018 -- (Healthcare Sales & Marketing Network) -- Aquestive Therapeutics, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company's New Drug Application for clobazam Oral Soluble Fil... Biopharmaceuticals, Drug Delivery Aquestive Therapeutics, clobazam, Oral Soluble Film, Lennox-Gastaut syndrome (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 18, 2018 Category: Pharmaceuticals Source Type: news

Bluegrass Vascular Announces Enrollment Of First Patients In U.S. Pivotal Trial
SAN ANTONIO, Jan. 18, 2018 -- (Healthcare Sales & Marketing Network) -- Bluegrass Vascular Technologies, a private medical technology company focused on innovating lifesaving devices and methods for vascular access, today announced the enrollment of its f... Devices, Interventional Bluegrass Vascular Technologies, Surfacer System, Surfacer Inside-Out (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 18, 2018 Category: Pharmaceuticals Source Type: news

Lannett Names Timothy C. Crew To Board Of Directors
PHILADELPHIA, Jan. 18, 2018 -- (Healthcare Sales & Marketing Network) -- Lannett Company, Inc. (NYSE: LCI) today announced that Timothy C. Crew, the company's recently appointed chief executive officer (CEO), has been added to the Lannett Company Board of... Biopharmaceuticals, Generic, Personnel Lannett Company (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 18, 2018 Category: Pharmaceuticals Source Type: news

Avion Pharmaceuticals announces approval of first NDA in the oral contraceptive category
ATLANTA, Jan. 17, 2018 -- (Healthcare Sales & Marketing Network) -- Avion Pharmaceuticals, LLC, the makers of the Prenate® line of prescription prenatal vitamins, received approval of its new drug application (NDA) for the oral contraceptive Balcoltra... Biopharmaceuticals, FDA Avion Pharmaceuticals, Balcoltra, levonorgestrel, ethinyl estradiol (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 17, 2018 Category: Pharmaceuticals Source Type: news

Catalyst OrthoScience Strengthens Its Board of Directors with The Addition of Greg Rainey
NAPLES, Fla., Jan. 16, 2018 -- (Healthcare Sales & Marketing Network) -- Catalyst OrthoScience, Inc., a cutting-edge medical device company focused on the upper extremity orthopedics market, today announced the addition of Greg Rainey to its Board of Dire... Devices, Orthopaedic, Personnel Catalyst OrthoScience, Total Shoulder, stemless (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 17, 2018 Category: Pharmaceuticals Source Type: news

International Biophysics obtains FDA 510k clearance for the FloPump(R) 32 centrifugal heart pump
AUSTIN, Texas, Jan. 17, 2018 -- (Healthcare Sales & Marketing Network) -- International Biophysics Corporation, a global medical device manufacturer based in Austin, Texas, announced they have received FDA 510k clearance for their FloPump 32 centrifugal d... Devices, Cardiology, FDA International Biophysics, FloPump 32, disposable heart pump (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 17, 2018 Category: Pharmaceuticals Source Type: news

Relmada Therapeutics Acquires Global Rights to Develop and Market Dextromethadone for Treatment of Disorders of the Nervous System
Agreement positions company to advance dextromethadone program to its full potential targeting a wide range of neurological conditions including certain rare genetic diseases NEW YORK, Jan. 17, 2018 -- (Healthcare Sales & Marketing Network) -- Relmada ... Biopharmaceuticals, Neurology Relmada Therapeutics, dextromethadone (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 17, 2018 Category: Pharmaceuticals Source Type: news

Novartis granted US FDA Priority Review for Kymriah(TM) (tisagenlecleucel), formerly CTL019, for adults with r/r DLBCL
Filing acceptance marks second Priority Review granted to Kymriah by the FDA for two distinct indications, underscoring the potential of first ever FDA-approved CAR-T therapy EMA granted accelerated assessment to Kymriah for children, young adults with ... Biopharmaceuticals, Oncology Novartis, Kymriah, tisagenlecleucel, CAR-T , cell therapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 17, 2018 Category: Pharmaceuticals Source Type: news

Pharming Announces FDA Acceptance for Review of Supplemental Biologics License Application for RUCONEST(R) for Prophylaxis of Hereditary Angioedema Attacks
LEIDEN, Netherlands, January 17, 2018 -- (Healthcare Sales & Marketing Network) -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext Amsterdam: PHARM) announced today that the U.S. Food and Drug Administration (FDA) has accep... Biopharmaceuticals Pharming Group, RUCONEST, hereditary angioedema (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 17, 2018 Category: Pharmaceuticals Source Type: news

Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps FDA is taking to enhance transparency of clinical trial information to support innovation and scientific inquiry related to new drugs
SILVER SPRING, Md., Jan. 16, 2018 -- (Healthcare Sales & Marketing Network) -- Scientific progress and new drug innovation don't take place in a vacuum. The exchange of information that informs decisions to undertake research, invest in new scientific ende... Biopharmaceuticals, FDA clinical trials (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 16, 2018 Category: Pharmaceuticals Source Type: news

Geoffrey B. Davis Joins GT Biopharma's Board of Directors
LOS ANGELES, January 16, 2018 -- (Healthcare Sales & Marketing Network) -- GT Biopharma Inc. (OTCQB: GTBP) and (Euronext Paris: GTBP.PA) today announced that Geoffrey B. Davis will join GT Biopharma's Board of Directors effective immediately. Mr. Davis is... Biopharmaceuticals, Oncology, Personnel GT Biopharma, Natural Killer Cell Engagers, antibody-drug conjugate (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 16, 2018 Category: Pharmaceuticals Source Type: news

Sequence Bio appoints Dr. Michael S. Phillips as Chief Scientific Officer to lead genomic research and drug discovery projects
Genomics expert Dr. Phillips will lead Sequence Bio's scientific efforts to understand and cure diseases using genomic and longitudinal health data from - and for the benefit of - the Newfoundland and Labrador population ST. JOHN'S, Jan. 16, 2018 -- (He... Biopharmaceuticals, Personnel Sequence Bio (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 16, 2018 Category: Pharmaceuticals Source Type: news

Eiger BioPharmaceuticals Announces Phase 2 LIBERTY Study in Pulmonary Arterial Hypertension Did Not Meet Primary Endpoint
End of Phase 2 Meeting Scheduled for HDV in February 2018 Phase 2 Readouts for PBH and Lymphedema in Second Half 2018 PALO ALTO, Calif., Jan. 16, 2018 -- (Healthcare Sales & Marketing Network) -- Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), focuse... Biopharmaceuticals Eiger BioPharmaceuticals, pulmonary arterial hypertension, ubenimex (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 16, 2018 Category: Pharmaceuticals Source Type: news

MabVax Therapeutics Holdings, Inc. Provides Business Strategy Update
Company makes solid progress in advancing discussions with multiple third parties in the evaluation of strategic options that are expected to unlock significant value Management on track to execute value-driving corporate and clinical milestones in the ... Biopharmaceuticals, Oncology MabVax Therapeutics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 16, 2018 Category: Pharmaceuticals Source Type: news

RXi Pharmaceuticals Announces Business Strategy to Focus on Immuno-Oncology Programs to Accelerate Growth
Company to capitalize on proprietary self-delivering RNAi platform (sd-rxRNA®) that has now been proven to be safe and effective in clinical trials Partner/Out-license robust dermatology and ophthalmology franchises to strengthen the Company's balan... Biopharmaceuticals, Oncology RXi Pharmaceuticals (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 16, 2018 Category: Pharmaceuticals Source Type: news

Novartis new data reinforces superiority of Cosentyx(R) versus Stelara(R) in achieving skin clearance for psoriasis patients
Results from CLARITY study show Cosentyx® (secukinumab) was significantly more effective than Stelara® (ustekinumab) in delivering clear and almost clear skin at 12 weeks and at 16 weeks(1) Data support findings from the CLEAR study, which found... Biopharmaceuticals Novartis, Cosentyx, secukinumab, plaque psoriasis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 16, 2018 Category: Pharmaceuticals Source Type: news

Nitto Avecia Pharma Services Appoints Raymond Kaczmarek as President
IRVINE, Calif., Jan. 15, 2018 -- (Healthcare Sales & Marketing Network) -- Nitto Avecia Pharma Services, Inc. (Avecia Pharma), a leading CGMP contract development and manufacturing organization (CDMO), announced today that it has appointed Raymond Kaczmar... Biopharmaceuticals, Personnel Avecia Pharma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 15, 2018 Category: Pharmaceuticals Source Type: news

BD and Check-Points Receive CE Mark for Next-generation Resistant Bacteria Screening Test
New Test Provides Diagnostic Results Up to 10 Times Faster Than Traditional Tests FRANKLIN LAKES, N.J., and WAGENINGEN, The Netherlands, Jan. 15, 2018 -- (Healthcare Sales & Marketing Network) -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leadin... Diagnostics, Regulatory BD , Check-Points Health, BD MAX (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 15, 2018 Category: Pharmaceuticals Source Type: news

Olympus PeriView FLEX TBNA Needle Brings New Capabilities to Early Diagnosis of Lung Disease
The First TBNA Needle Designed for Peripheral Bronchoscopy Featuring Increased Flexibility and Smaller Outer Diameter, Brings the Periphery Within Reach CENTER VALLEY, Pa., Jan. 15, 2018 -- (Healthcare Sales & Marketing Network) -- Olympus, a global te... Devices, Product Launch Olympus, PeriView FLEX needle, transbronchial needle aspiration (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 15, 2018 Category: Pharmaceuticals Source Type: news

USRM Reaches Key Sales Milestone of Proprietary Adipocell(TM) Product
Company Poised to Be Industry Leader in Autologous Adipose Stem Cell Treatments SUNRISE, Fla., Jan. 15, 2018 -- (Healthcare Sales & Marketing Network) -- U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem... Regenerative Medicine U.S. Stem Cell, Adipocell, stem cell (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 15, 2018 Category: Pharmaceuticals Source Type: news

Nuvo Pharmaceuticals (Ireland) Limited Acquires U.S. Product Rights to Resultz(R) from Piedmont Pharmaceuticals LLC
Resultz was FDA cleared in May 2017 Company now owns Resultz product rights globally Opens access to ~US$255 million head lice market MISSISSAUGA, ON, Jan. 15, 2018 -- (Healthcare Sales & Marketing Network) - Nuvo Pharmaceuticals Inc.™ (Nuvo or t... Biopharmaceuticals, Acquisitions Nuvo Pharmaceuticals, Piedmont Pharmaceuticals, Resultz, isopropyl myristate (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 15, 2018 Category: Pharmaceuticals Source Type: news

Boston Scientific Announces Positive Results from WHISPER Spinal Cord Stimulation Study
Randomized controlled trial demonstrates effectiveness of long-term treatment with sub-perception spinal cord stimulation MARLBOROUGH, Mass., Jan. 12, 2018 -- (Healthcare Sales & Marketing Network) -- Boston Scientific Corporation (NYSE: BSX) today ann... Devices, Neurology Boston Scientific, spinal cord stimulation, neuromodulation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 12, 2018 Category: Pharmaceuticals Source Type: news

Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA decision to seek additional time to reassess rule that would have changed longstanding practices for how the agency determined the 'intended use' of medical products
SILVER SPRING, Md., Jan. 12, 2018 -- (Healthcare Sales & Marketing Network) -- The FDA is committed to ensuring that we have the right policies and processes in place to fulfill our public health mission. This includes providing clear rules to medical prod... Devices, FDA intended use (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 12, 2018 Category: Pharmaceuticals Source Type: news

GSK receives FDA approval for expanded indication for FLUARIX(R) QUADRIVALENT (Influenza Vaccine) for persons 6 months and older
PHILADELPHIA, Jan. 12, 2018 -- (Healthcare Sales & Marketing Network) -- GSK [LSE/NYSE: GSK] announced today it has received approval from the US Food and Drug Administration's (FDA) Center for Biologics Evaluation and Research expanding the indication fo... Biopharmaceuticals, FDA GSK, FLUARIX QUADRIVALENT, Influenza Vaccine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 12, 2018 Category: Pharmaceuticals Source Type: news

BD Statement on FDA Warning Letter for Preanalytical Systems Business Unit
FRANKLIN LAKES, N.J., Jan. 12, 2018 -- (Healthcare Sales & Marketing Network) -- BD (Becton, Dickinson and Company) (NYSE: BDX) issued the following statement in response to receiving a warning letter from the U.S. Food and Drug Administration for its Pre... Devices, FDA BD , Vacutainer, blood collection tube (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 12, 2018 Category: Pharmaceuticals Source Type: news

FDA warns Becton Dickinson and Company of significant violations of the law as part of ongoing investigation into lead testing issues
SILVER SPRING, Md., Jan. 11, 2018 -- (Healthcare Sales & Marketing Network) -- The U.S. Food and Drug Administration today issued a warning letter to Becton Dickinson (BD) & Company that cited several violations of federal law, including marketing signific... Devices, FDA BD , Vacutainer, blood collection tube (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 12, 2018 Category: Pharmaceuticals Source Type: news

Resverlogix Receives FDA Protocol Acceptance for the Ongoing Phase 3 BETonMACE Trial
CALGARY, Alberta, Jan. 11, 2018 -- (Healthcare Sales & Marketing Network) -- Resverlogix Corp. (“Resverlogix” or the "Company") (TSX:RVX) and the Resverlogix BETonMACE Clinical Steering Committee (CSC), represented by Professor Kausik Ray (Chair)... Biopharmaceuticals, Cardiology, FDA Resverlogix, Apabetalone, bromodomain, diabetes, coronary artery disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 11, 2018 Category: Pharmaceuticals Source Type: news

New Study Shows Superiority of Intrathecal Baclofen Therapy (ITB Therapy(SM)) Over Oral Medication for the Treatment of Severe Post-Stroke Spasticity
Therapy Delivered via the Medtronic SynchroMed(TM) II Infusion System DUBLIN - January 11, 2018 -- (Healthcare Sales & Marketing Network) -- Medtronic plc (NYSE:MDT) today announced the publication of results from the 'Spasticity In Stroke-Randomised St... Devices, Drug Delivery, Neurology Medtronic, Intrathecal Baclofen Therapy, baclofen, SynchroMed, Stroke (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 11, 2018 Category: Pharmaceuticals Source Type: news

First Patient Enrolled in U.S. IDE Study To Evaluate the Potential of New Device To Reduce Stroke Risk in Atrial Fibrillation Patients
Biosense Webster, Inc. Launches U.S. Clinical Study to Evaluate the Safety and Efficacy of the WaveCrest® Left Atrial Appendage Occlusion System IRVINE, Calif., Jan. 11, 2018 -- (Healthcare Sales & Marketing Network) -- Johnson & Johnson Medical De... Devices, Interventional Cardiology Biosense Webster, Johnson & Johnson, WaveCrest, Left Atrial Appendage Occlusion (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 11, 2018 Category: Pharmaceuticals Source Type: news

Boston Scientific Receives U.S. FDA Approval for Spectra WaveWriter(TM) Spinal Cord Stimulator System
System offers non-opioid treatment option with multiple therapies for people with chronic pain MARLBOROUGH, Mass., Jan. 11, 2018 -- (Healthcare Sales & Marketing Network) -- Boston Scientific Corporation (NYSE: BSX) today announced that the U.S. Food a... Devices, FDA Boston Scientific, Spectra WaveWriter, Spinal Cord Stimulator (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 11, 2018 Category: Pharmaceuticals Source Type: news

New Kleiner Spine Graft Delivery Tool Improves Outcomes for Patients, Surgeons, Hospitals and Payers
DENVER, Jan. 10, 2018 -- (Healthcare Sales & Marketing Network) -- Kleiner Device Labs today announced full commercial availability of a new spinal bone graft delivery tool, the KG® 1, featuring a patented design that facilitates less-invasive procedu... Devices, Oncology, Neurosurgery, Product Launch Kleiner Device Labs, bone graft (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 10, 2018 Category: Pharmaceuticals Source Type: news

Morphotek Announces FDA Acceptance Of Investigational New Drug Application For Next-Generation Farletuzumab Antibody-Drug Conjugate MORAb-202
EXTON, Pa., Jan. 10, 2018 -- (Healthcare Sales & Marketing Network) -- Morphotek®, Inc., a subsidiary of Eisai Inc., announced today that the U.S. Food and Drug Administration (FDA) accepted an Investigational New Drug (IND) Application for MORAb-202,... Biopharmaceuticals, Oncology, FDA Morphotek, Eisai, Farletuzumab, eribulin (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 10, 2018 Category: Pharmaceuticals Source Type: news